| 產品名稱 |
Felid herpesvirus 1 |
| 商品貨號 |
B226003 |
| Classification |
Herpesviridae, Varicellovirus |
| Deposited As |
Feline rhinotracheitis virus |
| Agent |
Felid herpesvirus 1 |
| Strain |
FVRm |
| Applications |
No HA or hemolysin produced. |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Throat swab from a cat infected with cloned virus exposed to chemical mutagens |
| Product Format |
freeze-dried |
| Storage Conditions |
-70°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
Attenuated strain. Stable at 31-37°C. Antigenicity is specific for the virus. No cross-reactions. No HA or hemolysin produced. Physical properties are the same as for other herpesviruses. |
| Effect on Host |
Herpes type focal CPE in feline cells |
| Recommended Host |
feline kidney cells; domestic cat cat; feline fetus cells in tissue culture |
| Growth Conditions |
Temperature: 31°C Incubation: 2 days |
| Name of Depositor |
Norden Labs. |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
Throat swab from a cat infected with cloned virus exposed to chemical mutagens |
| References |
Davis E. Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom. US Patent 4,031,204 dated Jun 21 1977
|
